Another potential coronavirus treatment

Israeli biotech Redhill has announced that another of its pipeline medicines RHB-107 (upamostat) is to be tested by the US National Institute of Allergy and Infectious Diseases (NIAID) against SARS-CoV2, the virus that causes COVID-19. (Redhill’s Opaganib is already saving lives.)

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *